Skip to menu Skip to content Skip to footer

The preclinical development of Tosedostat for the treatment of childhood acute myeloid leukaemia (2012-2013)

Experts

Dr Andy Moore

ATH - Associate Professor
Child Health Research Centre
Faculty of Medicine
Andy Moore
Andy Moore